Andrew joined the Board of Directors in July 2011 and has 30 years of experience working with emerging growth companies. He is currently Vice Chairman of Special Equities Group, LLC, a privately held investment banking firm affiliated with Bradley Woods & Co. Ltd. (previously affiliated with Chardan Capital Markets, LLC). From June 2013 until July 2015 he served as Managing Director of Emerging Growth Equities, an investment bank, and Vice President of Sabr, Inc., a family investment group. He was previously President of LOMUSA Limited, an investment banking firm. From 2009 to 2012, Andrew served as Vice Chairman and Chief Marketing Officer of Unterberg Capital, LLC, an investment advisory firm that he co-founded. He was also Vice Chairman and Head of Equity Capital Markets of Merriman Capital LLC, an investment banking firm, and served on the board of the parent company, Merriman Holdings, Inc. He currently serves on the boards of Oncocyte Corporation, Asterias Biotherapeutics, Inc., and Comhear Inc.
This person is not in the org chart